MD20010076A - Microbial sanogenic preparation for digestive tract sanitation and treatment of disbacteriosis - Google Patents

Microbial sanogenic preparation for digestive tract sanitation and treatment of disbacteriosis Download PDF

Info

Publication number
MD20010076A
MD20010076A MDA20010076A MD20010076A MD20010076A MD 20010076 A MD20010076 A MD 20010076A MD A20010076 A MDA20010076 A MD A20010076A MD 20010076 A MD20010076 A MD 20010076A MD 20010076 A MD20010076 A MD 20010076A
Authority
MD
Moldova
Prior art keywords
disbacteriosis
sanitation
treatment
digestive tract
microbial
Prior art date
Application number
MDA20010076A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Мария ТИМОШКО
Анна ЛЕОРДА
Original Assignee
Институт Физиологии И Санокреатологии Академии Наук Молдовы
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Физиологии И Санокреатологии Академии Наук Молдовы filed Critical Институт Физиологии И Санокреатологии Академии Наук Молдовы
Priority to MDA20010076A priority Critical patent/MD20010076A/en
Publication of MD20010076A publication Critical patent/MD20010076A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention refers to medicine, namely to the microbial preparations and may be used for sanitation of the digestive tract and treatment of disbacteriosis.Summary of the invention consists in that the preparation contains new strains of Bifidobacterium longum-Bl-77, Lactobacillus plantarum-Lp-47 and Lactobacillus fermenti-Lf-115, and one dose of preparation contains Bl-279-(7…8)·1010, Lp-47-(2…3)·108 and Lf-115-(8…9)·107 of living cells to 1 g.
MDA20010076A 2001-03-22 2001-03-22 Microbial sanogenic preparation for digestive tract sanitation and treatment of disbacteriosis MD20010076A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20010076A MD20010076A (en) 2001-03-22 2001-03-22 Microbial sanogenic preparation for digestive tract sanitation and treatment of disbacteriosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20010076A MD20010076A (en) 2001-03-22 2001-03-22 Microbial sanogenic preparation for digestive tract sanitation and treatment of disbacteriosis

Publications (1)

Publication Number Publication Date
MD20010076A true MD20010076A (en) 2002-11-30

Family

ID=62142880

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20010076A MD20010076A (en) 2001-03-22 2001-03-22 Microbial sanogenic preparation for digestive tract sanitation and treatment of disbacteriosis

Country Status (1)

Country Link
MD (1) MD20010076A (en)

Similar Documents

Publication Publication Date Title
TR200103439T2 (en) Diet to be used for the prevention or treatment of hyperoxaluria.
TR200101699T2 (en) Oral lactobacilli application for the prevention and treatment of urogenital infections
WO2002083879A3 (en) Immunotherapy based on dendritic cells
BR9900972A (en) Use of a combination of lactobacilli for the preparation of a composition for treating vaginosis and vaginitis, and pharmaceutical compositions thus prepared.
WO2000071138A3 (en) Oral administration of lactobacillus for the maintenance of health in women
ATE304366T1 (en) PHARMACEUTICAL FORMULATION CONTAINING LACTOBACILLUS CASEI RHAMNOSUS
GR3026758T3 (en) Lactobacillus strains of human origin, their compositions and uses thereof
MXPA05000880A (en) Probiotics for gut neuromuscular functions.
HUP0301349A2 (en) Formulations for il-11
BR0314511A (en) Selection and Use of Lactic Acid Bacteria to Reduce Helicobater Inflammation
PL365246A1 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
MXPA04005346A (en) Use of micro-organisms for a directed delivery of substances to specific parts of the gut.
DE69622855D1 (en) PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN LACTOBACILLUS PLANTARUM AND ARGININE
SE9704584L (en) Preparation of Conjugated Linoleic Acid
HUP0303977A3 (en) Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical nad alimentary fields
WO2003013559A1 (en) Bile acid absorbent/adsorbent
AU2003249856A1 (en) Rapidly disintegrating tablet
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
WO2002000208A3 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined with specific pharmaceutical active agents
MD20010076A (en) Microbial sanogenic preparation for digestive tract sanitation and treatment of disbacteriosis
MD20010055A (en) Microbial sanogenic preparation for prevention and treatment of intestinal disbacteriosis
MD2211G2 (en) Remedy for treatment of parodontium affections
AU5069500A (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
WO2007071986A8 (en) Use of whole bacterial cells (actinomycetales) for maternal administration to modulate offspring immune response